|Year : 2022 | Volume
| Issue : 1 | Page : 80-84
|Integrative medicine enhances motor and sensory recovery in guillain–Barre syndrome – A case study
Akhila Soman1, Umesh Chikkanna1, Kishore Kumar Ramakrishna1, Hemant Bhargav1, Shivakumar Venkataram1, Nishitha Lakshmi Jasti1, Shubham Sharma1, Velayutham Selva Ganapathy2, Shivarama Varambally1
1 Department of Integrative Medicine, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India
2 Department of Physiotherapy and Neurorehabilitation, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka, India
Click here for correspondence address and email
|Date of Submission||22-Dec-2021|
|Date of Decision||24-Jan-2022|
|Date of Acceptance||25-Jan-2022|
|Date of Web Publication||21-Mar-2022|
| Abstract|| |
Guillain–Barre syndrome (GBS) is a heterogenous group of immune-mediated conditions affecting peripheral nerves. About 40% of patients treated with standard dosage of plasma exchange or intravenous immunoglobulins do not improve in the first 4 weeks following treatment. Add-on treatment from traditional medical approaches such as Yoga therapy and Ayurveda are increasingly being sought for rehabilitation of patients with chronic neurological disorders. The current case study reports the clinical utility of adjunct Yoga and Ayurveda treatment in the treatment of residual symptoms of GBS.
Keywords: Ayurveda, Guillain–Barre syndrome, panchakarma, yoga
|How to cite this article:|
Soman A, Chikkanna U, Ramakrishna KK, Bhargav H, Venkataram S, Jasti NL, Sharma S, Ganapathy VS, Varambally S. Integrative medicine enhances motor and sensory recovery in guillain–Barre syndrome – A case study. Int J Yoga 2022;15:80-4
|How to cite this URL:|
Soman A, Chikkanna U, Ramakrishna KK, Bhargav H, Venkataram S, Jasti NL, Sharma S, Ganapathy VS, Varambally S. Integrative medicine enhances motor and sensory recovery in guillain–Barre syndrome – A case study. Int J Yoga [serial online] 2022 [cited 2022 Oct 3];15:80-4. Available from: https://www.ijoy.org.in/text.asp?2022/15/1/80/340027
| Introduction|| |
Guillain–Barre syndrome (GBS) is a heterogenous group of immune-mediated polyradiculoneuropathy causing rapidly progressive limb weakness. The incidence of GBS is 0.5–2/100,000/year, with a risk of <1 in 1000 over the lifetime of an individual. Clinically, GBS progresses over a period of time, beginning with numbness and weakness over lower extremities. Around 50% of patients develop maximum weakness by 2nd week, 80% by 3rd week, and 90% by the end of 4th week. Proven therapies are intravenous immunoglobulins and plasma exchange, which have been shown to be efficacious in the management of GBS. However, significant number of patients report sensory-motor residual symptoms that persist for a long time (ranging from 6 months to 3 years) in spite of following all conventional treatment approaches. These residual symptoms significantly affect functionality and quality of life of the patient. Thus, the present case report aims at providing preliminary evidence toward utility of integrative medicine (IMD) (combining conventional treatment modalities with traditional Indian systems of medicine, namely Yoga and Ayurveda) in managing residual sensorimotor symptoms in a patient with GB syndrome.
| Case Report|| |
A 70-year-old male patient who was wheelchair bound (with knee gaiters and artificial foot orthoses [AFO] for knee and foot support) visited the outpatient department (OPD) of IMD, NIMHANS with the complaints of weakness in both the lower limbs and difficulty in walking, burning sensation and numbness in lower limbs for 5 months, and difficulty in holding objects in both hands for the past 4 months.
The patient was relatively alright 5 months back when he started complaining of sudden onset numbness and cold sensation over distal aspects of both the lower limbs. The symptoms started progressing proximally within a day and involved the upper limbs as well in the next 2 days. From 3rd day, the patient started developing difficulty in walking, buckling of the knees and noticed slipping of the footwear while trying to walk. He also noticed difficulty in gripping objects and combing his hair at the same time. By the 5th day of onset of symptoms, the patient was bed-ridden and became dependent on his family for all activities of daily living (ADL). The patient provided a history of taking the first dose of vaccination for COVID-19 infection (Covishield vaccine) 19 days before the onset of symptoms. As the symptom's worsened, the patient was admitted to a tertiary care private hospital (5th day postsymptoms onset) after testing him for COVID-19 infection (reverse transcription-polymerase chain reaction [RT-PCR] test was negative). There was no history of fever, diarrhea, swallowing or speech disturbances, respiratory distress, or bowel bladder incontinence. Diagnosis of GBS was made based on cerebrospinal fluid analysis which showed albuminous cytological dissociation and nerve conduction study (NCS) suggestive of demyelinating polyneuropathy. After 5 days of admission, although the patient started showing improvement in power of upper limbs and anti-gravity muscles of the lower limb, he started developing symptoms of cough with expectoration and fever. His RT-PCR report for COVID-19 infection came out to be positive. The patient was managed as per the guidelines and stabilized and was discharged after 10 days of admission. Three days postdischarge patient tested negative for COVID-19 infection.
Later, after 10 days postdischarge, the patient again developed symptoms of cough with expectoration, difficulty in swallowing for liquids and solids, and speech difficulty. Within a day, he experienced weakness and numbness in all four limbs similar to the previous episode of GBS and was readmitted to the same private tertiary care hospital as before. He was diagnosed with left vocal cord paralysis by an ENT surgeon. Later, the patient started receiving feeds through nasogastric tube and was referred to NIMHANS, Bengaluru for further management.
The very next day, the patient was admitted at NIMHANS, a diagnosis of recurrent GBS was made, and the patient was managed with seven cycles of large volume plasmapheresis (LVPP). At this time, he was unable to indicate bowel bladder movements and was on diaper and condom catheter. After 4 days of admission, the patient developed severe respiratory distress and was put on mechanical ventilation. Gradually, he was weaned off ventilator support in the next 20 days of hospitalization. The patient started taking oral feeds in the next 7 days. Further, after five cycles of LVPP, the patient started to notice recovery in motor power in the form of anti-gravity movements of all the four extremities. Supportive treatment including symptomatic treatment for pain, anti-hypertensives, deep vein thrombosis prophylaxis, and antibiotics was given. Inputs from the departments of neuro-rehabilitation, psychiatric social work and speech and audiology were also taken. The patient showed improvement in motor and bulbar symptoms. The patient was discharged and was advised to undergo neuro-rehabilitation practices including physiotherapy.
After this, within a week of discharge, the patient was admitted under the Department of Neuro-rehabilitation and underwent physiotherapy for the next 30 days and was advised bilateral knee gaiters and AFO to aid walking. With physiotherapy, the patient showed improvement in hand grip strength, he was able to stand with support and AFO and was able to walk few steps with the help of a walker. However, the patient still complained of easy fatiguability, paraesthesia and difficulty in feeling the floor on bare feet, and weakness in the lower limbs at the time of discharge (after 45 days of treatment in neuro-rehabilitation). He was advised to continue physiotherapy practices postdischarge at home. However, the patient did not report further improvement in neurological deficits and sensory symptoms even after 30 days of physiotherapy practice at home.
In this condition, the patient and his family decided to explore Integrative therapies of yoga and Ayurveda and visited the OPD services of the Department of IMD, NIMHANS. It was decided to admit the patient and one caretaker (his son) to the in-patient services of IMD.
Clinical findings and diagnostic assessments
Chief complaints at the time of admission were burning sensation over both the lower extremities, numbness in distal part of both the lower extremities and inability to feel the floor on bare feet, weakness in arms, and difficulty in walking. Examination of sensory system revealed abnormalities in superficial touch, pain, temperature, two-point discrimination, and joint position sense. Examination of motor system revealed diplegic presentation of lower extremities and para-paresis like presentation in upper extremities. Power was 1/5 in both lower extremities and it was 4/5 in both upper extremities. Hypertonia was observed in both the upper and lower extremities, and deep tendon reflexes were absent. There was no wasting of the muscles. Among the test for coordination, the patient was able to perform finger-nose test, whereas he was unable to perform heel shin test and tandem walking. Cranial nerve examination revealed no abnormality. Prefunctional Ambulation Profile Score showed impairment in gait. NCS showed reduced velocity in Rt. Median and Rt. Ulnar nerve.
Integrative therapeutic intervention
The patient continued to follow all conventional medicine advices and medications as prescribed by the neurologist (Tab. Terol LA 2 mg HS, Tab. Optineuron 1OD, Tab. Maxgalin-NT 1BD, Tab. Calinept 1OD) including physiotherapy practices. As an add-on to the above, a lifestyle regimen of integrative yoga and ayurveda management was added. Based on presenting symptoms, a diagnosis of Sarvangavata with avarana pathology involving kapha, vyana, and udana vata was considered. Details of IMD treatment are provided below,
Systematic Panchakarma (Ayurveda-based herbal detoxification) procedure of 23 days was performed. [Table 1] and [Table 2] provide the treatment details.
Daily supervised sessions of yoga (50 min per day) 6 days a week were conducted for 18 days followed by home practice with an objective of improving balance, muscle strength, and sensory symptoms. Home practice was continued with the help of Tele-yoga and shared video. [Table 3] provides the details of the Yoga intervention.
Follow-up and outcomes
Subject was assessed at time points-baseline, 18th day of admission, and 30 days postdischarge. During discharge, sensory deficits showed full recovery in terms of superficial touch, pain and temperature from 10 to 2 assessed using visual analog scale. Muscle power of upper limbs improved from 4/5 and 1/5 to 5/5 and 4/5 in upper and lower extremities, respectively. The patient was able to walk without AFO or any support for a distance of 50 m without fatigue. NCS showed mild improvement in conduction velocity in Rt. Median Nerve (from 17.2 meter/s to 19 meter/s) and Rt. Ulnar Nerve (from 24.7 meter/s to 26.1 meter/s), respectively [Table 6]. There was an accompanying improvement in the performance of ADLs and other criteria as revealed from the scales applied on the day of admission, day of discharge, and first follow-up after a month. Improvements were also observed in muscle strength and ADL [Table 4] and [Table 5]. Balance index showed reduction in fall risk [[Figure 1] fall risk test], whereas the overall stability index and overall sway index improved by 72% and 78%, respectively, along with an improvement in sensory integration of balance by 29% [[Table 5]-postural stability progress report and [Figure 2]-clinical test of sensory integration of balance]. The above-mentioned improvements sustained at 30-day postdischarge [Table 4], [Table 5], [Table 6].
| Discussion|| |
GBS bears close resemblance with Sarvanga vata which is included under Vata Vyadhi. The general line of treatment of vata vyadhi; Snehana, Swedana, Asthapana, Anuvasana was adopted in the patient. Sarvanga dhara with Dhanyamla has shown to have anti-oxidant and anti-inflammatory action. Basti is considered as the best treatment for Vata Vyadhi. It helps in achieving Vatanulomana (downward regulation of vata) and Sroto shuddi (Clearing the channels) and it is the choice of treatment for disease afflicting the Madhyama Roga Marga (Disease affecting vital organs). Studies suggest improvement in ADL, enhanced vagal activity and changes in gut microbiome post Basti chikitsa. Shashtika shali pinda sweda in various neurological conditions suggests improvement in motor deficits post, ADL, has nourishing effect on muscles, and peripheral nerves.
Further, studies show persistence of sensory and motor deficits postconventional therapy significantly affect functionality and quality of life of the GBS patients. Case reports on Ayurveda in GBS and randomized control trial on Yoga as add-on in GBS demonstrate significant improvement in motor and sensory deficits, reduction in pain, anxiety, depression score, and overall improvement in functional status. The current case report highlights the role of Integrative Ayurveda and Yoga therapy as an add-on to conventional care in improving overall functional status of GBS patient. At present, with limited evidence, we are not in position to comment on whether only Yoga and Ayurveda without conventional care would achieve such outcomes. We highlight the importance of integrative approach for the well-being of the patient.
| Conclusion|| |
Combining conventional pharmacological treatment approaches, neuro-rehabilitation (including physiotherapy), speech pathology, and audiology along with the traditional medicine of Yoga and Ayurveda may produce a synergistic effect. Integrated Ayurveda and Yoga-based lifestyle regimen may particularly be useful in improving residual sensory-motor deficits in patients with chronic neurological sequelae of GBS. This should be explored further through systematic trials.
| Acknowledgment|| |
Authors acknowledge support from the Department of Neurology, NIMHANS, Bengaluru.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Meena AK, Khadilkar SV, Murthy JM. Treatment guidelines for Guillain-Barré syndrome. Ann Indian Acad Neurol 2011;14 Suppl 1:S73-81.
Hartung HP. Infections and the Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1999;66:277.
Piccione EA, Salame K, Katirji B. Guillain-Barré syndrome and related disorders. In: Katirji B, Kaminski HJ, Ruff RL, editors. Neuromuscular Disorders in Clinical Practice. New York, NY: Springer; 2014. p. 573-603. Available from: https://doi.org/10.1007/978-1-4614-6567-6_28
. [Last accessed on 2021 Dec 07].
Jolles S, Sewell WA, Misbah SA. Clinical uses of intravenous immunoglobulin. Clin Exp Immunol 2005;142:1-11.
Leonhard SE, Mandarakas MR, Gondim FA, Bateman K, Ferreira ML, Cornblath DR, et al.
Diagnosis and management of Guillain-Barré syndrome in ten steps. Nat Rev Neurol 2019;15:671-83.
van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barré syndrome: Pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol 2014;10:469-82.
Yadavaji Trikamaji Acharya, editors. Charakasamhita of Agnivesha. Ch. 28., Ver. 25. Chikitsasthana; Vatavyadhichikitsaadhayaya. Varanasi: Chowkhambha; 2015.
Yadavaji Trikamaji Acharya, editors. Charakasamhita of Agnivesha. Ch. 28., Ver. 228. Chikitsasthana; Vatavyadhichikitsaadhayaya. Varanasi: Chowkhambha; 2015.
Yadavaji Trikamaji Acharya, editors. Charakasamhita of Agnivesha. Ch. 28., Ver. 224. Chikitsasthana; Vatavyadhichikitsaadhayaya. Varanasi: Chowkhambha; 2015.
Tubaki BR, Tarapure S. Ayurveda management of Guillain-Barre syndrome: A case report. J Ayurveda Integr Med 2020;11:73-7.
Ranasinghe S, Ediriweera ER. A pharmacological appraisal of Dhanyamla. 2015.
Shailaja U, Rao PN, Debnath P, Adhikari A. Exploratory study on the Ayurvedic therapeutic management of cerebral palsy in children at a tertiary care hospital of karnataka, India. J Tradit Complement Med 2014;4:49-55.
] [Full text]
Jaideep SS, Nagaraja D, Pal PK, Sudhakara D, Talakad SN. Modulation of cardiac autonomic dysfunction in ischemic stroke following Ayurveda (Indian System of Medicine) treatment. Evid Based Complement Alternat Med 2014;2014:634695.
Hegelmaier T, Lebbing M, Duscha A, Tomaske L, Tönges L, Holm JB, et al.
Interventional influence of the intestinal microbiome through dietary intervention and bowel cleansing might improve motor symptoms in Parkinson's disease. Cells 2020;9:376.
Vyas AG, Kori VK, Rajagopala S, Patel KS. Etiopathological study on cerebral palsy and its management by Shashtika Shali Pinda Sweda and Samvardhana Ghrita. Ayu 2013;34:56-62.
] [Full text]
Sendhilkumar R, Gupta A, Nagarathna R, Taly AB. “Effect of pranayama and meditation as an add-on therapy in rehabilitation of patients with Guillain-Barré syndrome – A randomized control pilot study”. Disabil Rehabil 2013;35:57-62.
Department of Integrative Medicine, National Institute of Mental Health and Neurosciences, Bengaluru, Karnataka
Source of Support: None, Conflict of Interest: None
[Figure 1], [Figure 2]
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6]
| Article Access Statistics|
| Viewed||1122 |
| Printed||52 |
| Emailed||0 |
| PDF Downloaded||101 |
| Comments ||[Add] |